Deputy Chief Minister of Delhi, Manish Sisodia said, 'Bharat Biotech wrote to us that they could not give us more doses, the central government is controlling the supply of the vaccine. I would say exporting 6.6 cr doses was the biggest mistake, We are forced to shut down 100 Covaxin-vaccination sites in 17 schools due to no supply’. Listen in.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
100 Covaxin sites will shut down as Bharat Biotech unable to provide more doses, says Manish Sisodia.
Deputy Chief Minister of Delhi, Manish Sisodia said, 'Bharat Biotech wrote to us that they could not give us more doses, the central government is controlling the supply of the vaccine. I would say exporting 6.6 cr doses was the biggest mistake, We are forced to shut down 100 Covaxin-vaccination sites in 17 schools due to no supply’. Listen in.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
100 Covaxin sites will shut down as Bharat Biotech unable to provide more doses, says Manish Sisodia
News video | 345 views
Bharat Biotech ने घटाई Covaxin की कीमत, अब राज्यों को 400 में मिलेगी
Visit Us - http://www.inhnews.in/
Follow Us On Twitter - https://twitter.com/inhnewsindia
Our WhatsApp Number - 9993022843
Link - https://youtu.be/Pdcoh-Zu2VU
Incoming Search Terms,
Latest News,
Corona Virus Vaccination || Bharat Biotech ने घटाई Covaxin की कीमत, अब राज्यों को 400 में मिलेगी
News video | 265 views
The central government has asked the Serum Institute of India and Bharat Biotech to lower the price of COVID vaccines, Covishield and Covaxin as India gears up to vaccinate all aged above 18 from May 1, official sources said on Monday.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Centre asks Serum Institute, Bharat Biotech to lower prices of Covishield, Covaxin: Sources
News video | 420 views
Bharat Biotech reduces Covaxin price for state governments by Rs 200, dose now at Rs 400. Earlier, each dose was priced at Rs 600. Watch
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
The Economic Times | A Times Internet Limited product
Covaxin prices slashed, Bharat Biotech to sell vaccine to state governments at Rs 400 per dose
News video | 308 views
कोरोनावायरस : भारत में कोरोनावायरस संक्रमण की तीसरी लहर इस साल सर्दियों के मौसम यानी नवंबर के अंत और दिसंबर की शुरुआत में आने की संभावना है। हेल्थ एक्सपर्ट्स का कहना है कि यह तीसरी लहर बच्चों के लिए ज़्यादा खतरनाक होगी। इस खबर ने पेरेंट्स की चिंता को बढ़ा दिया था क्योंकि देश में बच्चों के लिए कोरोना वायरस की कोई वैक्सीन अभी उपलब्ध नहीं है। लेकिन इस बीच बड़ी खुशखबरी ये मिल रही है कि जल्द ही 2 साल से 18 साल तक के बच्चों के लिए आने वाले दिन में कोरोना की वैक्सीन मिल सकती है। भारत बायोटेक की कोवैक्सीन जल्द ही बच्चों के लिए भी उपलब्ध हो जाएगी। आधिकारिक सूत्रों ने कहा है कि मंगलवार को सेंट्रल ड्रग्स स्टैंडर्ड कंट्रोल आर्गेनाईजेशन यानी (CDSCO ) की एक विशेष पैनल ने भारत बायोटेक की कोवाक्सिन को 2 से 18 साल की उम्र के ट्रायल के लिए मंजूरी दे दी है। यह ट्रायल विभिन्न जगहों पर 525 बच्चों पर होगा, जिनमें एम्स दिल्ली, एम्स पटना और मेडिट्रिना इंस्टीट्यूट ऑफ मेडिकल साइंसेज, नागपुर शामिल हैं। कोवैक्सीन पूरी तरह से स्वदेशी है, जिसे भारत बायोटेक ने बनाया है। अभी तक यह वैक्सीन 18 साल से ऊपर से लोगों के लिए ही बनाई गई है।
To Subscribe on Youtube:
https://www.youtube.com/user/punjabkesaritv
Follow us on Twitter :
https://twitter.com/punjabkesari
Like us on FB:
https://www.facebook.com/Pkesarionline/
Coronavirus : कोरोनावायरस की तीसरी लहर से Bharat Biotech की 'Covaxin' बचाएगी बच्चों को !
News video | 496 views
Bharat Biotech’s ‘Covaxin’ Gets Nod By SEC For Phase 2, 3 Trials On 2 to 18 Yrs | Catch News
Subject Expert Committee (SEC) gave nod to Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 human clinical trials on 2 to 18 years. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines being manufactured in India currently and has been developed by Bharat Biotech.
#BharatBiotech #Covaxin #CovidVaccine #catchnews #CatchNewsToday
For more videos, subscribe to our channel: https://goo.gl/bkDSLj
Check out Catch News for more news: http://www.catchnews.com/
Follow Catch News here -
Facebook:https://bit.ly/2xD3NKZ
Twitter: https://bit.ly/2NG3rhr
Instagram: https://bit.ly/30mh2vE
--------------------------------------------------------------------------------------------
Also, Follow Catch in Hindi: http://hindi.catchnews.com/
Catch is a contemporary new digital platform about the ideas and events shaping the world. It aims to filter and provide news-on-the-run for an impatient new generation. It offers greater insight for influencers and the deeper consumer of news. When opinions are shrill and polarized, we hope to create a middle ground and build bridges. When there is a set thinking, we hope to stand apart and go against the wind. The world is complex, exciting, layered, evolving, always interesting. We hope to be the same.
Lots of videos and lots more in the pipeline. Stay tuned.
Bharat Biotech’s ‘Covaxin’ Gets Nod By SEC For Phase 2, 3 Trials On 2 to 18 Yrs | Catch News
News video | 316 views
Subject Expert Committee (SEC) gave nod to Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 human clinical trials on 2 to 18 years. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines being manufactured in India currently and has been developed by Bharat Biotech.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Bharat Biotech’s 'Covaxin' gets SEC nod for phase 2-3 clinical trials on 2 to 18 year-olds
News video | 256 views
The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare. Bharat Biotech will conduct trials in 525 healthy volunteers. 'In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28,' it said.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 yrs
News video | 330 views
Two government-owned companies have entered into an agreement with Bharat Biotech to share the vaccine formula in order to manufacture Covid-19 vaccines.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Two PSUs enter into pact with Covaxin maker Bharat Biotech to produce Covid-19 vaccines
News video | 633 views
Watch 100 Years old now NIRADHAR.....Government unable to provide ADHAR...! With HD Quality
News video | 855 views
IND vs SA | World Cup T20 2024 | Match Preview and Stats | Fantasy 11 | Crictracker
Welcome to the exhilarating showdown between India vs South Africa in the World Cup T20 2024 season! Get ready for an electrifying clash as these two powerhouse teams, fueled by raw talent and strategic brilliance, lock horns for cricketing supremacy.
Join us as the India, led by their charismatic captain, face off against the South Africa, determined to showcase their prowess on the pitch. With star-studded lineups boasting top-tier international players and emerging talents, expect nothing short of cricketing excellence and heart-stopping moments.
Don't miss a single moment of the action, drama, and excitement as these teams battle it out in the high-stakes arena of World Cup T20 2024. From breathtaking boundaries to strategic masterstrokes, witness every twist and turn in this epic showdown.
IND vs SA | World Cup T20 2024 | Final | Match Preview and Stats | Fantasy 11 | Crictracker
Sports video | 7592 views
IND vs ZIM | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Welcome to the exhilarating showdown between India vs Zimbawe in the T20 series! Get ready for an electrifying clash as these two powerhouse teams, fueled by raw talent and strategic brilliance, lock horns for cricketing supremacy.
Join us as the India, led by their charismatic captain, face off against the Zimbawe, determined to showcase their prowess on the pitch. With star-studded lineups boasting top-tier international players and emerging talents, expect nothing short of cricketing excellence and heart-stopping moments.
Don't miss a single moment of the action, drama, and excitement as these teams battle it out in the high-stakes arena of this T20 series. From breathtaking boundaries to strategic masterstrokes, witness every twist and turn in this epic showdown.
IND vs ZIM | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Sports video | 719 views
Watch as our employees try to guess the famous cricketers from just a few clues. Can you beat them at their own game? Test your cricket knowledge and see how many cricketers you can guess correctly. Don’t forget to like, comment, and subscribe for more fun office challenges and cricket trivia! #CricketChallenge #OfficeFun #guessthecricketer #crickettrivia
Office Fun Challenge: Guess the Cricketers? #office #crictracker #cricketlover ????
Sports video | 1263 views
IND vs BAN | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Welcome to the exhilarating showdown between India vs Bangladesh in the T20 series! Get ready for an electrifying clash as these two powerhouse teams, fueled by raw talent and strategic brilliance, lock horns for cricketing supremacy.
Join us as the India, led by their charismatic captain, face off against the Bangladesh, determined to showcase their prowess on the pitch. With star-studded lineups boasting top-tier international players and emerging talents, expect nothing short of cricketing excellence and heart-stopping moments.
Don't miss a single moment of the action, drama, and excitement as these teams battle it out in the high-stakes arena of this T20 series. From breathtaking boundaries to strategic masterstrokes, witness every twist and turn in this epic showdown.
IND vs BAN | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Sports video | 1420 views
IND vs SL | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Welcome to the exhilarating showdown between India vs Sri Lanka in the T20 series! Get ready for an electrifying clash as these two powerhouse teams, fueled by raw talent and strategic brilliance, lock horns for cricketing supremacy.
Join us as the India, led by their charismatic captain, face off against the Sri Lanka, determined to showcase their prowess on the pitch. With star-studded lineups boasting top-tier international players and emerging talents, expect nothing short of cricketing excellence and heart-stopping moments.
Don't miss a single moment of the action, drama, and excitement as these teams battle it out in the high-stakes arena of this T20 series. From breathtaking boundaries to strategic masterstrokes, witness every twist and turn in this epic showdown.
IND vs SL | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Sports video | 1132 views
IND vs SL | T20 | Final | Match Preview and Stats | Fantasy 11 | Crictracker
Welcome to the exhilarating showdown between India vs Sri Lanka in the T20 series! Get ready for an electrifying clash as these two powerhouse teams, fueled by raw talent and strategic brilliance, lock horns for cricketing supremacy.
Join us as the India, led by their charismatic captain, face off against the Sri Lanka, determined to showcase their prowess on the pitch. With star-studded lineups boasting top-tier international players and emerging talents, expect nothing short of cricketing excellence and heart-stopping moments.
Don't miss a single moment of the action, drama, and excitement as these teams battle it out in the high-stakes arena of this T20 Final. From breathtaking boundaries to strategic masterstrokes, witness every twist and turn in this epic showdown.
IND vs SL | T20 | Final | Match Preview and Stats | Fantasy 11 | Crictracker
Sports video | 792 views